<DOC>
	<DOC>NCT00838799</DOC>
	<brief_summary>This study is designed to evaluate the safety and efficacy of RGH-896 in patients with diabetic peripheral neuropathic pain.</brief_summary>
	<brief_title>Study of the Safety and Efficacy of RGH-896 in Patients With Diabetic Peripheral Neuropathic Pain</brief_title>
	<detailed_description />
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Diabetic Neuropathies</mesh_term>
	<mesh_term>Pregabalin</mesh_term>
	<criteria>Male or female outpatients 18 to 75 years of age A diagnosis of painful diabetic neuropathy Controlled blood glucose Willingness to wash out all analgesic medications used for DPNP Female patients either postmenopausal, surgically sterile, or practicing a medically acceptable method of contraception Female patients who are not pregnant Acute infections or cardiac problems Past use of pregabalin History of severe psychiatric disorder History of any amputation due to diabetes History of seizure disorder Active diabetic foot ulcers</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>diabetic</keyword>
	<keyword>peripheral</keyword>
	<keyword>neuropathic</keyword>
	<keyword>pain</keyword>
	<keyword>chronic</keyword>
	<keyword>diabetes</keyword>
</DOC>